Sedicidodici Srl

📍 Pordenone, Italy🗓 Founded 2005👥 6 employees💰 Last funded Jan 2006
Medical Device🌐 1612medical.com
Website LinkedIn
Smart Clot is a new tool for measuring the haemorrhagic and thrombogenic potential “ex vivo” of patients affected by cardiovascular diseases and/or thrombotic-haemorrhagic disorders, and for monitoring the effects of anticoagulation and antiplatelet drug therapy. The test is highly innovative insofar as it simultaneously measures platelet activation and the deposit of fibrin under controlled flux conditions (venous and arterial) using just one small whole blood sample. The Smart Clot test can be used by medical specialists (anaesthetists, haematologists, cardiologists, heart surgeons, etc.) to both accurately evaluate the disorder and to monitor the effects of antiplatelet and/or anticoagulation therapy. The Smart Clot test is set to become the “must have” device for haematologists and cardiologists and for any clinical situation or thrombotic disorder that requires the administration of antiplatelet or anticoagulant drugs such as cardiovascular diseases, neurological strokes, thrombosis, pulmonary embolisms, diabetes, surgery of any kind, etc.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2005
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Sedicidodici Srl?
Sedicidodici Srl has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Sedicidodici Srl last raise funding?
The most recent investment in Sedicidodici Srl recorded on gritt.io was in January 2006.
When was Sedicidodici Srl founded?
Sedicidodici Srl was founded in 2005.
What industry is Sedicidodici Srl in?
Sedicidodici Srl operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Sedicidodici Srl based?
Sedicidodici Srl is headquartered in Pordenone, Italy.